PIXUVRI Trademark

Trademark Overview

On Thursday, May 9, 2013, a trademark application was filed for PIXUVRI with the United States Patent and Trademark Office. The USPTO has given the PIXUVRI trademark a serial number of 85927825. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 13, 2017. This trademark is owned by Cell Therapeutics, Inc.. The PIXUVRI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of immunological and inflammatory diseases and for use in chemotherapy treatment, made in significant part of pixantrone and dimaleate; pharmaceutical preparations used for the treatment of cancer, made in significant part of pixantrone and dimaleate
pixuvri

General Information

Serial Number85927825
Word MarkPIXUVRI
Filing DateThursday, May 9, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 13, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 10, 2013

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"PIXANTRONE DIMALEATE"
Description of MarkThe mark consists of "PIXUVRI PIXANTRONE DIMALEATE" positioned to the left of a stylized flame design.
Goods and ServicesPharmaceutical preparations for the treatment of immunological and inflammatory diseases and for use in chemotherapy treatment, made in significant part of pixantrone and dimaleate; pharmaceutical preparations used for the treatment of cancer, made in significant part of pixantrone and dimaleate

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, May 16, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCTI BIOPHARMA CORP.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressSEATTLE, WA 98121
Party NameCell Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeattle, WA 98121
Party NameCell Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98121

Trademark Events

Event DateEvent Description
Monday, March 13, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, March 13, 2017ABANDONMENT - NO USE STATEMENT FILED
Saturday, July 30, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 29, 2016EXTENSION 5 GRANTED
Friday, July 22, 2016EXTENSION 5 FILED
Friday, July 22, 2016TEAS EXTENSION RECEIVED
Friday, May 6, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, May 6, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, January 29, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 28, 2016EXTENSION 4 GRANTED
Thursday, January 21, 2016EXTENSION 4 FILED
Thursday, January 21, 2016TEAS EXTENSION RECEIVED
Wednesday, July 8, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 7, 2015EXTENSION 3 GRANTED
Wednesday, July 1, 2015EXTENSION 3 FILED
Wednesday, July 1, 2015TEAS EXTENSION RECEIVED
Thursday, January 29, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 28, 2015EXTENSION 2 GRANTED
Tuesday, January 20, 2015EXTENSION 2 FILED
Tuesday, January 20, 2015TEAS EXTENSION RECEIVED
Friday, August 8, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 7, 2014EXTENSION 1 GRANTED
Wednesday, July 9, 2014EXTENSION 1 FILED
Tuesday, August 5, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, July 9, 2014TEAS EXTENSION RECEIVED
Wednesday, July 2, 2014AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, February 4, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 10, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 10, 2013PUBLISHED FOR OPPOSITION
Wednesday, November 20, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, November 4, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, October 31, 2013ASSIGNED TO LIE
Wednesday, October 16, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 15, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 15, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 15, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 4, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 4, 2013NON-FINAL ACTION E-MAILED
Wednesday, September 4, 2013NON-FINAL ACTION WRITTEN
Tuesday, August 27, 2013ASSIGNED TO EXAMINER
Friday, May 17, 2013NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, May 16, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, May 13, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

pixuvri treatment pharmaceutical made dimaleate part preparations significant pixantrone used cancer